Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Smith

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|October 17, 2019
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's diseaseEmily M Rocha, Briana R De Miranda, Sandra Castro, et al.
Disease Models & Mechanisms|April 14, 2022
The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsNicole K Polinski, Terina N Martinez, Sylvie Ramboz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2006
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscleAlon Chen, Bhawanjit Brar, Cheol Soo Choi, et al.
Brain Research|April 3, 2020
Antinociceptive effects of potent, selective and brain penetrant muscarinic M<sub>4</sub> positive allosteric modulators in rodent pain modelsSteven M Grauer, Raul Sanoja, Dominic Poulin, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A InhibitorShawn J Stachel, Richard Berger, Ashley B Nomland, et al.
Neuropharmacology|November 30, 2010
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of ratsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Diabetes|October 9, 2013
Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistanceAndrea R Nawrocki, Carlos G Rodriguez, Dawn M Toolan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2023
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein InclusionsCasey L Mahoney-Crane, Megha Viswanathan, Dreson Russell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Neuropharmacology|July 4, 2012
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkeySean M Smith, Jason M Uslaner, Christopher D Cox, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|October 17, 2019
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's diseaseEmily M Rocha, Briana R De Miranda, Sandra Castro, et al.
Disease Models & Mechanisms|April 14, 2022
The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsNicole K Polinski, Terina N Martinez, Sylvie Ramboz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2006
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscleAlon Chen, Bhawanjit Brar, Cheol Soo Choi, et al.
Brain Research|April 3, 2020
Antinociceptive effects of potent, selective and brain penetrant muscarinic M<sub>4</sub> positive allosteric modulators in rodent pain modelsSteven M Grauer, Raul Sanoja, Dominic Poulin, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A InhibitorShawn J Stachel, Richard Berger, Ashley B Nomland, et al.
Neuropharmacology|November 30, 2010
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of ratsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Diabetes|October 9, 2013
Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistanceAndrea R Nawrocki, Carlos G Rodriguez, Dawn M Toolan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2023
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein InclusionsCasey L Mahoney-Crane, Megha Viswanathan, Dreson Russell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Neuropharmacology|July 4, 2012
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkeySean M Smith, Jason M Uslaner, Christopher D Cox, et al.
Pageof 6